相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics
Franca Centorrino et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)
Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009
Juan A. Gallego et al.
SCHIZOPHRENIA RESEARCH (2012)
Antipsychotic Polypharmacy A Comprehensive Evaluation of Relevant Correlates of a Long-Standing Clinical Practice
Christoph U. Correll et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis
Lone Baandrup et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2012)
Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy
Susan M. Essock et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study
Fuminari Misawa et al.
BMC PSYCHIATRY (2011)
The incidence and associated risk factors for sudden unexplained death in psychiatric in-patients in England and Wales
Kirsten Windfuhr et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Antipsychotic Polypharmacy in the Treatment of Children and Adolescents in the Fee-for-Service Component of a Large State Medicaid Program
Robert J. Constantine et al.
CLINICAL THERAPEUTICS (2010)
Polypharmacy in schizophrenia
Mathias Zink et al.
CURRENT OPINION IN PSYCHIATRY (2010)
Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004
Franca Centorrino et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Trends in Adult Antipsychotic Polypharmacy: Progress and Challenges in Florida's Medicaid Program
Robert J. Constantine et al.
COMMUNITY MENTAL HEALTH JOURNAL (2010)
Identifying Clinically Questionable Psychotropic Prescribing Practices for Medicaid Recipients in New York State
Susan Essock et al.
PSYCHIATRIC SERVICES (2009)
Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
Christoph U. Correll et al.
SCHIZOPHRENIA BULLETIN (2009)
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Baojin Zhu et al.
BMC PSYCHIATRY (2008)
Benefits and risks of antipsychotic polypharmacy - An evidence-based review of the literature
Constantin Tranulis et al.
DRUG SAFETY (2008)
Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder
Marcia F. T. Rupnow et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs
Robert J. Valuck et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Antipsychotic polypharmacy trends among medi-cal beneficiaries with schizophrenia in San Diego County, 1999-2004
Todd P. Gilmer et al.
PSYCHIATRIC SERVICES (2007)
Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: Experience in a multistate Medicaid population, 1998-2003
Elaine H. Morrato et al.
CLINICAL THERAPEUTICS (2007)
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
Christoph U. Correll et al.
SCHIZOPHRENIA RESEARCH (2007)
Long-term antipsychotic polypharmacy in the VA health system: Patient characteristics and treatment patterns
Julie A. Kreyenbuhl et al.
PSYCHIATRIC SERVICES (2007)
Reduction of concurrent antipsychotic prescribing practices through the use of PSYCKES
Thomas Uttaro et al.
ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH (2007)
Long-term combination antipsychotic treatment in VA patients with schizophrenia
Julie Kreyenbuhl et al.
SCHIZOPHRENIA RESEARCH (2006)
High-cost use of second-generation antipsychotics under California's medicaid program
SM Stahl et al.
PSYCHIATRIC SERVICES (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Douglas Faries et al.
BMC PSYCHIATRY (2005)
A critical review of atypical antipsychotic utilization: Comparing monotherapy with polypharmacy and augmentation
SM Stahl et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Prevalence, trends, and factors associated with antipsychotic polypharmacy among medicaid-eligible schizophrenia patients, 1998-2000
R Ganguly et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
分享论文
